Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can rehearsing Real-Life ICU scenarios stop deadly infections?

NCT ID NCT07822971

Prevention Sponsor: Centre Hospitalier Régional Metz-Thionville Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers at one French hospital test whether repeated on-site simulation training helps ICU staff follow standard precautions more consistently. The training uses realistic scenarios that mimic common resuscitation situations, including interruptions and high cognitive load. The study compares infection rates and hand rub use before, during, and after the training period in adult ICU patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a simulation-based staff training programme called SimRéa
What this could lead to
If it works, hospitals could adopt simulation training to lower ICU infection rates and improve hand hygiene. This could offer a low-risk way to protect vulnerable patients.
What could go wrong
The study is not randomised, so other factors could explain any change in infection rates. It runs at a single hospital, so results may not apply elsewhere, and training effects can fade over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients hospitalized in the adult intensive care unit at CHR Metz-Thionville during the study period

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients hospitalized in the adult intensive care unit at CHR Metz-Thionville during the study period * Patients aged 18 years or older * Patients with a length of stay in the intensive care unit of 48 hours or more * Patients for whom the data necessary to assess the outcome measures are available in the electronic health record and/or hospital surveillance databases * Patients who have been informed about the use of their health data for research purposes, in accordance with the procedures established by the institution Exclusion Criteria: * Patients who, after being informed, objected to the use of their health data for this research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cross infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cross infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHR Metz-Thionville, Hôpital de Mercy

    RECRUITING

    Metz, 57085, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.